Latest News - Corporate Lawsuits

Monday, March 05, 2018

PTAB Upholds Eye Treatment Tool Patent

The Patent Trial and Appeal Board upheld a patent covering a tool used to treat an eye disorder, finding accused infringer MiBo Medical Group hadn’t shown the invention was obvious, accord…

Read the full story

Friday, February 23, 2018

Lenstec and Oculentis Settle Legal Dispute Over Patents for Bifocal IOLs

Lenstec has stated that it has won its UK patent suit against Oculentis for bifocal IOLs. Oculentis has withdrawn legal proceedings against Lenstec in the UK High Court and made a payment towards Lens…

Read the full story

Thursday, February 22, 2018

Mistrial Declared After Jury Deadlocks in Insider Trading Case of James Mazzo

A federal judge in California declared a mistrial Wednesday in the alleged insider-trading scheme of James Mazzo after the jury deadlocked on whether Mr. Mazzo gave insider trading tips about his comp…

Read the full story

Monday, February 12, 2018

Precision Lens Says It Will Fight Federal Allegations of Using Illegal Incentives

IOL distributor Precision Lens is vowing to fight a Justice Department lawsuit alleging the firm knowingly provided illegal incentives to eye surgeons like expensive hunting trips and vacations in ord…

Read the full story

Tuesday, January 02, 2018

Pershing Square, Valeant to Pay $290 Million to End Lawsuit

Activist investor Bill Ackman’s Pershing Square Holdings Ltd. and Valeant Pharmaceuticals International Inc. agreed to pay $290 million to settle investor claims that they engaged in insider tra…

Read the full story

Tuesday, December 26, 2017

Ocular Therapeutix Provides Legal Update

Ocular Therapeutix provided an update on legal matters related to the company’s manufacture of its product candidate, Dextenza (dexamethasone insert) 0.4mg. As the company previously disclose…

Read the full story

Monday, December 04, 2017

US Judge Refuses to Dismiss Allergan Suit Against Imprimis

A US judge has refused to dismiss an Allergan lawsuit that claims Imprimis Pharmaceuticals unfairly sells unapproved new drugs under the guise of compounding and engages in false and misleading advert…

Read the full story

Monday, October 16, 2017

Allergan Shares Slip As Judge Invalidates Patent on Top Selling Eye Drop

A federal judge struck down patents protecting one of Allergan’s top-selling drugs, sending shares in the company down nearly 5 percent, according to a report in the Financial Times. The Texa…

Read the full story

Monday, October 02, 2017

Shire Alleges Allergan Blocked Drug From Medicare Contracts

Shire filed an antitrust suit against Allergan alleging Allergan’s contracts with Medicare Part D drug plans for its Restasis eye drops effectively blocked access to Shire’s rival drug, ac…

Read the full story

Monday, September 18, 2017

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Allergan caused a lot of hand-wringing in the biotech community and excitement among patent lawyers, when the drugmaker announced it would transfer patents for Restasis, Allergan's longstandi…

Read the full story

Monday, September 11, 2017

Imprimis Releases Statement Regarding Allergan Lawsuit

Imprimis Pharmaceuticals responded to a press release issued by Allergan regarding a lawsuit Allergan USA filed against Imprimis. A portion of the Imprimis statement reads: "Imprimis will aggr…

Read the full story

Friday, September 08, 2017

Allergan Files Suits Against Imprimis Pharmaceuticals, Prescriber's Choice, and Sincerus Florida

Allergan USA has filed lawsuits against Imprimis Pharmaceuticals, Prescriber's Choice, and Sincerus Florida, alleging that those companies are unlawfully manufacturing and selling unapproved new d…

Read the full story

Tuesday, August 22, 2017

Minneapolis Eye Surgery Company Will Pay $12 Million in Alleged Kickbacks Case

A Minneapolis mobile ophthalmic company and its former CEO have agreed to pay $12 million to resolve allegations that it lured physicians with illegal kickbacks in exchange for their business for near…

Read the full story

Thursday, August 10, 2017

PhysIOL: Company Successful in Patent Infringement Action Protecting FINEVISION IOLs

PhysIOL has claimed that the Dusseldorf District Court in Germany has confirmed that VSY Biotechnology infringes the European Patent EP 2 503 962 of PhysIOL S.A. In its judgment on June 29, 2017, the …

Read the full story

Sunday, July 02, 2017

Allergan Settles Whistle-Blower Lawsuit

Allergan settled a whistle-blower lawsuit brought by two Philadelphia-area ophthalmologists who alleged the company provided paid speaking engagements, free business consulting, and other services as …

Read the full story
Load More